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Abstract
Background: Bacterial resistance to antibiotics is becoming a serious problem worldwide. The discovery of new
and effective antimicrobials and/or resistance modulators is necessary to tackle the spread of resistance or to
reverse the multi-drug resistance. We investigated the antibacterial and antibiotic-resistance modifying activities
of the methanol extracts from Allanblackia gabonensis, Gladiolus quartinianus and Combretum molle against 29
Gram-negative bacteria including multi-drug resistant (MDR) phenotypes.
Methods: The broth microdilution method was used to determine the minimal inhibitory concentrations (MIC) and
minimal bactericidal concentrations (MBC) of the samples meanwhile the standard phytochemical methods were
used for the preliminary phytochemical screening of the plant extracts.
Results: Phytochemical analysis showed the presence of alkaloids, flavonoids, phenols and tannins in all studied
extracts. Other chemical classes of secondary metabolites were selectively presents. Extracts from A. gabonensis and
C. molle displayed a broad spectrum of activity with MICs varying from 16 to 1024 μg/mL against about 72.41 % of
the tested bacteria. The extract from the fruits of A. gabonensis had the best activity, with MIC values below 100 μg/mL
on 37.9 % of tested bacteria. Percentages of antibiotic-modulating effects ranging from 67 to 100 % were observed
against tested MDR bacteria when combining the leaves extract from C. molle (at MIC/2 and MIC/4) with
chloramphenicol, kanamycin, streptomycin and tetracycline.
Conclusion: The overall results of the present study provide information for the possible use of the studied plant,
especially Allanblackia gabonensis and Combretum molle in the control of Gram-negative bacterial infections including
MDR species as antibacterials as well as resistance modulators.
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Background
Infectious diseases caused by multi-drug resistant (MDR)
Gram-negative bacteria are worldwide health concern,
causing increasingly morbidity and mortality particularly
in developing countries [1]. In Cameroon, previous studies
showed high levels of resistance to commonly used antibi-
otics in Gram-negative bacilli [2]. Several reports also
mentioned an increase in the hospital dissemination of
bacterial strains specifically those expressing drug efflux
mechanism [3, 4]. Against Gram-negative bacteria, the
discovery of efflux pump inhibitors (EPIs) is an attractive
strategy to combat MDR phenotypes [5]. EPI generally
interact with specific efflux pump proteins to restore the
susceptibility of MDR bacteria to antibiotics [6]. Medicinal
plants constitute an important source of chemotherapeu-
tic molecules, in regards to the chemical diversity found in
several species [7, 8]. In recent years, some plants have
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been successfully evaluated for their direct antibacterial
action, and for their antibiotic-modulation activity [9–12].
In the present work, we hypothesized that herbal medi-
cines traditionally used for the treatment of infectious dis-
eases could contain molecules acting as antibacterial and/
or antibiotic-resistance modulators. This study was there-
fore designed to investigate the in vitro antibacterial and
antibiotic-resistance modifying activities of the methanol
extracts from Allanblackia gabonensis Pellegr. (Clusiaceae),
Gladiolus quartinianus A. Rich (Iridaceae) and Combretum
molle R. Br. ex G. Don (Combretaceae) against Gram-
negative bacteria including multi-drug phenotypes. These
plants are traditionally used to manage various ailments in-
cluding bacterial related infections.
Methods
Plant materials and extraction
Medicinal plants used in this work were collected in dif-
ferent areas of Cameroon between January and April
2012. The plants were identified at the National Herbar-
ium (Yaoundé, Cameroon), where voucher specimens
were deposited under the reference numbers (Table 1).
The air-dried and powdered plant material was weighed
(300 g) and soaked in 1 L of methanol (MeOH) for 48 h
at room temperature. The filtrate obtained through
Whatman filter paper No. 1 was concentrated under
reduced pressure in vacuum to obtain the crude extracts.
All crude extracts were then kept at 4 °C until further uses.
Chemicals for antibacterial assays
Eight commonly used antibiotics including tetracycline
(TET), kanamycin (KAN), streptomycin (STR), ciprofloxa-
cin (CIP), norfloxacin (NOR), chloramphenicol (CHL),
ampicillin (AMP), erythromycin (ERY) (Sigma-Aldrich, St
Quentin Fallavier, France) were used. The p-Iodonitrotetra-
zolium chloride 0.2 % (INT) and phenylalanine arginine β-
naphthylamide (PAβN) (Sigma-Aldrich) were used as bacter-
ial growth indicator and efflux pumps inhibitor respectively.
Microorganisms and growth conditions
Pathogenic bacteria used in the study were Gram-negative
bacteria including MDR isolates (Laboratory collection)
and reference strains (American Type Culture Collection)
of Escherichia coli (ATCC8739, ATCC10536, AG100,
AG100A, AG100ATet, AG102, MC4100 W3110), Entero-
bacter aerogenes (ATCC13048, CM64, EA27, EA3, EA289,
EA298, EA294), Klebsiella pneumoniae (ATCC11296,
KP55, KP63, K24, K2), Enterobacter cloacae (ECCI69,
BM47, BM67), Pseudomonas aeruginosa (PA01, PA124)
and Providencia stuartii (ATCC29916, NEA16, PS2636,
PS299645) were used. Their features were previously
reported [37]. They were maintained at 4 °C and
sub-cultured on a fresh appropriate Mueller Hinton Agar
(MHA) for 24 h before any antibacterial test.
Preliminary phytochemical investigation
The plant extracts were screened for the presence of
major secondary metabolite classes such as alkaloids,
anthocyanins, anthraquinones, flavonoids, phenols,
saponins, sterols and triterpenes according to common
phytochemical methods previously described [38]. The
tests were based on visual observation of the change in
color or formation of precipitate after the addition of
specific reagents.
Antibacterial assays
MICs and MBCs of the plant extracts and chloram-
phenicol were determined by microdilution method
using rapid INT colorimetric assay [25, 39]. Briefly, the
samples were first dissolved in 10 % Dimethyl-sulfoxide
(DMSO)/Mueller Hinton Broth (MHB). The solution
obtained was then added to MHB and serially diluted
two fold (in a 96-well microplate). One hundred microli-
ters of inoculum (1.5× 106 CFU/mL) prepared in MHB
were then added. The plates were covered with a sterile
plate sealer and then agitated with a shaker to mix the
contents of the wells and incubated at 37 °C for 18 h.
The final concentration of DMSO was less than 2.5 %,
and did not affect the microbial growth. Wells contain-
ing MHB, 100 μL of inoculum, and DMSO at a final
concentration of 2.5 % served as the negative control.
The MIC of each sample was detected after 18 h of in-
cubation at 37 °C following addition of 40 μL INT
(0.2 mg/mL) and incubation at 37 °C for 30 min. Viable
bacteria reduced the yellow dye to a pink. The MIC was
defined as the lowest sample concentration that pre-
vented this change and that resulted in the complete in-
hibition of bacterial growth. The MBC of the sample
was determined by sub-culturing 50 μL of the suspen-
sions from the wells which did not show any growth
after incubation during MIC assays to 150 μl of fresh
broth, and re-incubated at 37 °C for 48 h before revela-
tion. The MBC was defined as the lowest concentration
of sample which completely inhibited the growth of bac-
teria [40]. Each assay was performed in three independ-
ent tests in triplicate. The samples were also tested in
the presence of phenylalanine arginine β-naphthylamide
(PAβN) at a final concentration of 20 μg/mL as previ-
ously described [41] on nine MDR bacteria. All assays
were performed three time in duplicate.
Antibiotic-modulation assay
To evaluate the antibiotic resistance modifying activity
of the extracts, the MIC of antibiotic was determined in
the presence or absence of the plant extracts. The 96-
wells plate modulation method, as described by Stavri
et al. [42] was used. Briefly, after serial dilutions of anti-
biotics (256–0.5 μg/mL), the plant extracts at their sub-
inhibitory concentrations (MIC/2 and MIC/4; selected
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Table 1 Plants used in the present study and evidence of their bioactivities
Samples, family, and
herbarium numbera
Traditional treatment Area of plant collection Known bioactive or potentially
active compounds
Screened biological activities of the crude




Dysentery, cold, toothache [13]; pain,
rheumatism, inflammations [14, 15].
Lebialem, South West region
of Cameroon; (4°10′N
9°14′E/4.167°N 9.233°E)
Not reported Crude extracts: Analgesic and anti-inlammatory
effect of aqueous extract of the stem bark [14];
crude methanol fruits extracts (40 μg/mL) showed
to inhibit growth of CCRF-CEM leukemia cells at




Infections of the skin, gut, urogenital
system, and upper respiratory tract [17],
gonorrhea, infectious conditions,




Not reported Methanol crude extract was reported to possess
moderate to significant anticancer activity
(IC50: 29.60 to10.57 μg/mL) against
drug-resistance cancer cell lines [16]
Combretum molle
R. Br. ex G. Don
(Combretaceae);
33311/ HNC
Fever, abdominal pains, convulsion, worm
infections, human immunodeficiency virus
(HIV)/acquiredimmune deficiency syndrome
(AIDS) related infections [19]; hookworm,
snake bite, leprosy, dysentery, general
body swellings, arthritic and other
inflammatory conditions, sterility,
constipation [20, 21]; Parasitic, protozoan,
infectious diseases [22], malaria [23]
University of Dschang, West
region of Cameroon; (6°30′N
10°30′E/6.500°N 10.500°E)
Mollic acid glucoside [21]);
β-D-glucopyranosyl 2α,3β,6β-trihydroxy-
23-galloylolean-12-en-28-oate,combregenin,
arjungenin, arjunglucoside I, and
combreglucoside [24] .
Crude extracts were evaluated for: antibacterial
activity [25–27]; antimycobacterial [28]; antifungal
effects [29]; antimalarial [30]; anthelmintic activities
[31]; anti-HIV by inhibition of ribonuclease-H [19];
Cytotoxic effects against T-24 bladder cancer cells
[32]; Anti-inflammatory activity [24]; in vitro
anticholinesterase and inhibitory effects on Rabbit
Breathing [33]. Compounds: mollic acid glucoside
(MAG) showed analgesic, anti-inflammatory properties
in mice and rats [21], cardiovascular effect [34];
hypoglycaemic effect [35]; Punicalgin and CM-A,
two isolated tannins were assessed for their anti-HIV
activity against human immunodeficiency virus
type 1 (HIV-1) and type 2 (HIV-2) [36].


















after preliminary study; Table 2), were added and inocu-
lation was done. The MIC was determined as described
above. Modulation factors (MF), calculated as MIC Anti-
biotic alone/MIC Antibiotic alone + Extract; was used to express
the modulating or synergy effects of the plant extracts.
Results
Phytochemical Screening of the plant extracts
The main classes of secondary metabolites for each ex-
tract were screened and the results are summarized in
Table 3. Tannins, flavonoids, alkaloids and phenols were
present in all tested extracts. Others classes of botanicals
were selectively distributed in different plant extracts.
Antibacterial activity of the plant extracts
The results summarized in Table 4 show that all extracts
were active on at least three of bacterial strains, with
MIC values varying from 16 to 1024 μg/mL. Extracts
from Combretum molle leaves (CML) and Allanblackia
gabonensis displayed the most important spectrum of
activity. Their inhibitory effects were observed on
72.41 % (27/29) for CML of the tested bacteria, 58.62 %
(17/29) for leaves (AGL), 75.86 % (22/29) for flower (AGFl)
Table 2 MIC of antibiotics in combination with extracts at sub-inhibitory concentrations against P. aeruginosa PA124
Plant extracts a Antibiotcs b
CHL AMP ERY KAN STR TET CIP NFX
ATB Alone 64 - 128 128 64 16 32 128
AGR MIC/2 64(1) - (NA) 128(1) 16(2) 32(2) 16(1) 32(1) 128(1)
MIC/4 64(1) - (NA) 128(1) 16(2) 64(1) 16(1) 32(1) 128(1)
MIC/8 64(1) - (NA) 128(1) 128(1) 64(1) 16(1) 32(1) 128(1)
MIC/16 64(1) - (NA) 128(1) 128(1) 64(1) 16(1) 32(1) 128(1)
AGB MIC/2 64(1) - (NA) 128(1) 128(1) 32(2) 8(2) 32(1) 128(1)
MIC/4 64(1) - (NA) 128(1) 128(1) 64(1) 16(1) 32(1) 128(1)
MIC/8 64(1) - (NA) 128(1) 128(1) 64(1) 16(1) 32(1) 128(1)
MIC/16 64(1) - (NA) 128(1) 128(1) 64(1) 16(1) 32(1) 128(1)
AGL MIC/2 64(1) - (NA) 128(1) 16(2) 64(1) 16(1) 32(1) 128(1)
MIC/4 64(1) - (NA) 128(1) 128(1) 64(1) 16(1) 32(1) 128(1)
MIC/8 64(1) - (NA) 128(1) 128(1) 64(1) 16(1) 32(1) 128(1)
MIC/16 64(1) - (NA) 128(1) 128(1) 64(1) 16(1) 32(1) 128(1)
AGF MIC/2 32(2) - (NA) 128(1) 64(2) 32(2) 16(1) 32(1) 128(1)
MIC/4 64(1) - (NA) 128(1) 64(2) 32(2) 16(1) 32(1) 128(1)
MIC/8 64(1) - (NA) 128(1) 64(2) 64(1) 16(1) 32(1) 128(1)
MIC/16 64(1) - (NA) 128(1) 64(2) 64(1) 16(1) 32(1) 128(1)
AGFl MIC/2 64(1) - (NA) 128(1) 64(2) 64(1) 8(2) 32(1) 128(1)
MIC/4 64(1) - (NA) 128(1) 64(2) 64(1) 16(1) 32(1) 128(1)
MIC/8 64(1) - (NA) 128(1) 64(2) 64(1) 16(1) 32(1) 128(1)
MIC/16 64(1) - (NA) 128(1) 128 64(1) 16(1) 32(1) 128(1)
GQW MIC/2 64(1) - (NA) 128(1) 64(2) 32(2) 16(1) 32(1) 128(1)
MIC/4 64(1) - (NA) 128(1) 64(2) 64(1) 16(1) 32(1) 128(1)
MIC/8 64(1) - (NA) 128(1) 128 64(1) 16(1) 32(1) 128(1)
MIC/16 64(1) - (NA) 256(0.5) 128 64(1) 16(1) 32(1) 128(1)
CML MIC/2 32(2) - (NA) 64(2) 64(2) 32(2) 4(4) 16(2) 16(2)
MIC/4 32(2) - (NA) 64(2) 64(2) 32(2) 4(4) 16(2) 16(2)
MIC/8 64(1) - (NA) 128(−) 64(2) 64(1) 8(2) 32(1) 128(1)
MIC/16 641) - (NA) 128(−) 64(2) 64(1) 8(2) 32(1) 128(1)
a: Plan extracts: (AGFl : Allanblackia gabonensis Flowers, AGF : Allanblackia gabonensis Fruits, AGL: Allanblackia gabonensis Leaves, AGB: Allanblackia gabonensis
Stem barks, AGR: Allanblackia gabonensis Root barks, GQW: Gladiolus quartinianus Whole plant, CML: Combretum molle Leaves); b: Antibiotics (TET: tetracycline,
KAN: kanamycin, STR: streptomycin, ERY: erythromycin, CHL: chloramphenicol, NFX: norfloxacin, CIP: ciprofloxacin, AMP: ampicillin); − : MIC not detected at up to
256 μg/mL; (): Modulation factor or gain of activity; NA: Not applicable, Values in bold represent the modulation factor ≥ 2, the selected extracts and its
concentrations to be used on others MDR bacteria
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and bark (AGB), 79.31 % (23/29) for bark and 86.20 %
(25/29) for fruits (AGF) extracts from Allanblackia
gabonensis. AGF was the best extract with MIC values
below 100 μg/mL on 38 % (11/29) of the tested bacteria.
CML mostly showed moderate activity with MIC values
ranging from 128–512 μg/mL. The activity of CHL was
comparable to that of plant extracts in certain cases.
This was the case with AGF, AGFl and AGR against
K. pneumoniae Kp55 (64 μg/mL); AGF against K. pneumo-
niae Kp53 (64 μg/mL), and AGFl against P. stuartii PS2636
(32 μg/mL). MICs values equal or above 1024 μg/mL
were obtained with the extract from G. quartinianus
(GQW). MBCs values were generally equal or below
1024 μg/mL (Table 4).
Antibacterial activity of the extracts in the presence of an
Efflux Pumps Inhibitors
In the present work, extracts were combined with PAβN;
However, no significant increase of the activities of the
tested plant extracts was generally observed. Only AGL
showed 4 times decrease of MICs against E. coli AG102
and E. cloacae BM67. In contrast, PAβN significantly
improved the activity of the reference drug, CHL (more
than 16 times) on MDR bacteria used (Table 5).
Antibiotic resistance modifying activities of the
plant extracts
Tables 2, 6 and 7 highlights the potentiating effects of
the extracts on the activity of eight commonly used
antibiotics. The most important modulating effects were
observed of association CML with aminoglycosides
(kanamycin and streptomycin), the potentiation effects
varying from 77.78 to 88.89 % and from 66.67 to 77.78 %
at MIC/2 and MIC/4 respectively; and with tetracycline
(100 % and 77.78 % at MIC/2 and MIC/4 respectively)
(Table 6). The modulating effects also ranged between 50
to 67 %, with the extract from A. gabonensis fruits (AGF)
when combined at (MIC/2) with the some antibiotics. At
MIC/4, AGF showed synergy less than 50 % on the tested
bacteria with all antibiotics (Table 7). The most significant
increases of antibiotic activity in the presence of plant
extracts were noted with the association of streptomycin
and CML and AGF on E. coli AG100ATet, with more than
128 fold and 64-fold decreases of MIC respectively. No in-
crease of activity was noted with ampicillin, a β-lactamine
when it was combined with plant extracts.
Discussion
Medicinal plants are potential source of antimicrobial
agents used in the treatment of infectious diseases [43, 44].
According to Kuete et al. [45, 46], the antibacterial activity
of a plant extract is considered significant when the MICs
are below 100 μg/mL, moderate when 100 ≤MIC ≤
625 μg/mL and weak when MIC are above 625 μg/mL.
Consequently, the antibacterial activities of the tested ex-
tracts particularly those from A. gabonensis (AGF, AGR,
AGB and AGFl) and C. molle (CML) were generally mod-
erated (Table 4). Significant activities were recorded with
AGF, AGR, AGB, and AGFl respectively on 37.93 %,
24.14 %, 20.70 % and 17.24 %. This highlights the good
antibacterial potential of the tested extracts. The overall
activity recorded with most of the studied extracts could
be considered significant, especially those from A. gabo-
nensis and C. molle [47]. When analyzing carefully the
MIC and MBC results for the extract, it can be noted
that MBC ≤ 4 were obtained with these samples on most
of the tested bacterial species, suggesting their killing
effects [48].
PAβN is a potent inhibitor of RND systems like
AcrAB-TolC in Enterobacteriaceae or MexAB-OprM in
P. aeruginosa used in the present work [49, 50]; The
activity observed when chloramphenicol was tested in the
presence of PAβN increased significantly, confirming that
the tested bacteria are good models of efflux pumps-
expressing bacteria.
Reversal of multi-drug resistance appears today as
another attempt to mitigate the spread of resistance in
bacteria. In recent years, many plants extracts and sec-
ondary metabolites have been evaluated as modulators
of the antibiotic activity in efflux pumps in MDR
Table 3 Qualitative phytochemical composition of the plant extracts
Plant samples Phytochemical composition
Triterpenes Flavonoids Alkaloids Anthraquinones Phenols Anthocyanines Saponins Tannins Steroids
Allanblackia gabonensis - + + + + + _ + -
- + + - + + - + -
+ + + + + + + + -
+ + + + + + + + -
+ + + - + + + + -
Gladiolus quartinianus + + + - + + - + +
Combretum molle - + + - + - + + +
(+): present; (−): absent
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Table 4 Minimal inhibitory concentration (MIC) and minimal bactericidal (MBC) of the plant extracts and CHL on the studied bacterial species






Flowers (AGFl) Fruits (AGF) Leave (AGL) Stem barks (AGB) Root barks (AGR)
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
E. coli
ATCC8739 64 512 16 256 512 - 64 256 64 256 1024 - 256 1024 2 32
ATCC10536 64 512 32 256 512 1024 32 128 64 256 1024 - 512 512 1 32
AG100 - - 1024 - - 1024 - 512 - - - 512 1024 8 128
AG100A 128 512 64 256 512 512 128 512 128 512 - - 512 1024 0.5 64
AG100ATet 1024 - 512 - - - 1024 - 1024 - - - 1024 - 64 256
AG102 1024 - 1024 - - - 1024 - 1024 - - - 1024 - 32 >256
MC4100 256 512 128 1024 512 - 256 512 512 - 1024 - 256 1024 32 >256
W3110 256 - 256 512 512 1024 64 512 256 1024 - - 512 1024 8 128
E. aerogenes
ATCC13048 128 1024 16 128 256 1024 32 512 32 512 1024 - 1024 - 8 64
CM64 - - 1024 - - - - - - - 1024 - >256 >256
EA27 512 1024 128 512 512 - 128 512 128 512 - - 1024 1024 64 256
EA3 1024 - - - 1024 - 512 - 512 - - - 1024 - 128 >256
EA289 1024 - 1024 - - - - - 1024 - - - 1024 - 128 >256
EA298 1024 - - - - - - - - - - 1024 - 64 >256
EA294 128 256 64 512 256 1024 64 512 128 1024 1024 - 128 512 16 64
E. cloacae
ECCI69 - - 1024 - - - - - 1024 - - - - - >256 >256
BM47 - - 1024 - - - 1024 - - - - - - - >256 >256
BM67 - - - - - - - - - - - - 1024 - >256 >256
K. pneumoniae
ATCC11296 128 1024 16 128 256 1024 32 256 32 256 1024 - 512 1024 4 32
KP55 64 256 64 256 1024 - 256 1024 64 512 - - 512 1024 64 256
KP63 128 256 64 256 256 1024 128 512 128 256 - - 512 - 64 256
K24 - - 1024 - 1024 - 1024 - - - 1024 - 32 256


















Table 4 Minimal inhibitory concentration (MIC) and minimal bactericidal (MBC) of the plant extracts and CHL on the studied bacterial species (Continued)
P. stuartii
ATCC29916 64 512 16 128 256 512 128 512 64 256 - - 512 512 8 128
NEA16 1024 - 1024 - - - - - - - - 1024 - 64 256
PS2636 32 512 64 128 512 - 256 256 128 512 - - 512 - 32 256
PS299645 128 1024 128 - 128 512 256 512 128 512 - - 512 512 32 256
P. aeruginosa
PA01 512 1024 512 512 512 512 1024 512 - 1024 - 512 1024 32 256
PA124 - - - - - - - - - 1024 - 64 >256


















Table 5 MIC of the samples in the absence and presence of PAβN on the selected MDR bacterial species
MDR Bacteria
used






Flowers (AGFl) Fruits (AGF) Leaves (AGL) Stem bark (AGB) Root barks (AGR)
Alone + PAβN alone + PAβN Alone + PAβN alone + PAβN Alone + PAβN Alone + PAβN Alone + PAβN Alone + PAβN
E. coli
AG100ATet 1024 1024 1024 512 - - 1024 1024 1024 1024 - - 1024 1024 64 ≤2
AG102 1024 1024 1024 512 - 512 1024 1024 124 1024 - - 1024 1024 32 ≤2
E. aerogenes
CM64 - - 1024 1024 - - - - - - - - 1024 1024 256 16
EA289 1024 1024 1024 1024 - 1024 - - 1024 1024 - - 1024 512 128 8
E. cloacae
ECCI69 - - 1024 1024 - - - - - - - - - - >256 128
BM67 - 1024 - - - 512 - - - - - - 1024 1024 >256 32
K. pneumoniae
K24 - 1024 1024 1024 - - 1024 1024 1024 1024 - - 1024 1024 32 2
P. stuartii -
NEA16 - - 1024 1024 - - - 1024 - 1024 - - 1024 1024 64 8
P. aeruginosa


















Table 6 Resistance modulating effect of the methanol leaves extract from Combretum molle at its sub-inhibitory concentrations on selected
Antibioticsa Extract
concentrations
MDR Bacteria used % Modulating
effectbE. coli E. aerogenes K. pneumoniae P. stuartii P. aeruginosa
AG100 AG102 AG100Tet CM64 EA289 EA298 K24 NEA16 PA124
AMP 0 - - - - - - - - -
MIC/2 -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) 0
MIC/4 -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) 0
CHL 0 8 32 64 256 128 64 64 64 64
MIC/2 8(1) 16 (2) 32(2) 256(1) 64(2) 8(8) 64(1) 16(4) 32(2) 66.65
MIC/4 8(1) 32(1) 64(1) 256(1) 64(2) 32(2) 64(1) 32(2) 32(2) 44.44
CIP 0 ≤0.5 ≤0.5 128 64 128 1 128 1 32
MIC/2 ≤0.5(NA) ≤0.5 64(2) 64(1) 128(1) 1(1) 64(2) 1(1) 16(2) 33.33
MIC/4 ≤0.5(NA) ≤0.5 64(2) 64(1) 128(1) 1(1) 64(2) 1(1) 16(2) 33.33
NFX 0 ≤0.5 ≤0.5 256 - 128 8 - 4 128
MIC/2 ≤0.5(NA) ≤0.5 128(2) 64(>4) 128(1) 8(1) -(NA) 4(1) 64(2) 33.33
MIC/4 ≤0.5(NA) ≤0.5 256(1) 64(>4) 128(1) 8(1) -(NA) 4(1) 64(2) 22.22
KAN 0 64 4 8 2 16 32 4 16 128
MIC/2 4(16) 4(1) 4(2) ≤0.5(>4) 2(8) 32(1) 2(2) 4(4) 64(2) 77.78
MIC/4 8(8) 4(1) 4(2) 1(2) 4(4) 32(1) 2(2) 8(2) 64(2) 77.78
STR 0 >64 - - 4 16 32 4 32 64
MIC/2 >64(NA) 256 (≥2) 4(>64) 1(4) 4(4) 16(2) 1(4) 8(4) 32(2) 88.89
MIC/4 >64(NA) - 128(>2) 2(2) 4(4) 32(1) 2(2) 16(2) 32(2) 66.67
ERY 0 32 64 - - 64 16 128 16 128
MIC/2 8(4) 64(1) 256(>1) -(NA) 64(1) 4(4) 128(1) 4(4) 64(2) 44.44
MIC/4 8(4) 64(1) -(NA) -(NA) 64(1) 16(1) 128(1) 8(2) 128(1) 22.22
TET 0 2 8 32 16 32 4 16 4 16
MIC/2 ≤0.5(>4) 2(4) 8(4) 4(4) 8(4) 2(2) 8(2) 2(2) 4(4) 100
MIC/4 1(2) 8(1) 32(1) 8(2) 8(4) 2(2) 8(2) 2(2) 4(4) 77.78
a: Antibiotics (TET: tetracycline, KAN: kanamycin, STR: streptomycin, ERY: erythromycin, CHL: chloramphenicol, NFX: norfloxacin, CIP: ciprofloxacin, AMP: ampicillin; - : MIC not detected at up to 256 μg/mL; ():
Modulation factor or gain of activity; b : Percentage of Antibiotic’s modulation Activity by the Plant extracts; Indications in bold represent the modulation factor ≥ 2, antibiotics having a percentage of modulating effect


















Table 7 Resistance modulating effect of the Fruits methanol extract from Allanblackia gabonensis at its sub-inhibitory concentrations on selected MDR bacteria
Antibioticsa Extract
concentrations
MDR Bacteria used % Modulating
effectbE. coli E. aerogenes K. pneumoniae P. stuartii P. aeruginosa
AG100 AG102 AG100ATet CM64 EA289 EA298 K24 NEA16 PA124
AMP 0 - - - - - - - - -
MIC/2 -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) 0
MIC/4 -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) -(NA) 0
CHL 0 8 32 64 256 128 64 64 64 64
MIC/2 8(1) 32(1) 64(1) 256(1) 128(1) 32(2) 32(2) 64(1) 32(2) 33.33
MIC/4 8(1) 32(1) 64(1) 256(1) 128(1) 64(1) 64(1) 64(1) 64(1) 0
CIP 0 ≤0.5 ≤0.5 128 64 128 1 128 1 32
MIC/2 ≤0.5(NA) ≤0.5(NA) 64(2) 32(2) 128(1) 2(0.5) 128(1) 1(1) 32(1) 33.33
MIC/4 ≤0.5(NA) ≤0.5(NA) 64(2) 64(1) 128(1) 2(0.5) 128(1) 1(1) 32(1) 11.11
NFX 0 ≤0.5 ≤0.5 256 - 128 8 - 4 128
MIC/2 1(≤0.5) ≤0.5(NA) 256(1) 128(>2) 128(1) 8(1) -(NA) 4(1) 128(1) 11.11
MIC/4 1(≤0.5) ≤0.5(NA) 256(1) -(NA) 128(1) 8(1) -(NA) 4(1) 128(1) 0
KAN 0 64 4 8 2 16 32 4 16 128
MIC/2 2(32) 4(1) 2(4) ≤0.5(≥4) 1(16) 32(1) 2(2) 16(1) 64(2) 66.67
MIC/4 4(16) 4(1) 4(2) 2(1) 4(4) 32(1) 4(1) 16(1) 64(2) 44.44
STR 0 >64 - - 4 16 32 4 32 64
MIC/2 >64(NA) -(NA) 2(>128) 2(2) 2(8) 32(1) 4(1) 16(2) 32(2) 55.56
MIC/4 >64(NA) -(NA) 8(>32) 2(2) 4(4) 32(1) 4(1) 32(1) 32(2) 44.44
ERY 0 32 64 - - 64 16 128 16 128
MIC/2 16(2) 64(1) 256(>1) -(NA) 64(1) 16(1) 128(1) 16(1) 128(1) 11.11
MIC/4 16(2) 64(1) -(NA) -(NA) 64(1) 16(1) 128(1) 16(1) 128(1) 0
TET 0 2 8 32 16 32 4 16 4 16
MIC/2 1(2) 4(2) 8(4) 4(4) 4(8) 4(1) 16(1) 2(2) 16(1) 66.67
MIC/4 1(2) 8(1) 8(4) 4(4) 8(4) 4(1) 16(1) 4(1) 16(1) 44.44
a: Antibiotics (TET: tetracycline, KAN: kanamycin, STR: streptomycin, ERY: erythromycin, CHL: chloramphenicol, NFX: norfloxacin, CIP: ciprofloxacin, AMP: ampicillin; - : MIC not detected at up to 256 μg/mL; ():
Modulation factor or gain of activity; b : Percentage of antibiotic’s modulation activity by the Plant extracts; Indications in bold represent the modulation factor ≥ 2 and antibiotics having a percentage of modulating


















bacteria [9–11, 37, 51–54]. Herein, we demonstrated
that a beneficial effect of the combination of the
extracts from the leaves of C. molle (CML) and fruits of
A. gabonensis (AGF) with CHL, KAN and STR could be
achieved. Synergistic or modulating effects of the plant
extracts particularly C. molle extract with antibiotics
were noted on more than 70 % of the tested MDR
bacteria, suggesting that some of their constituents can
act as efflux pump inhibitors [51]. These constituents
might act by blocking the efflux pumps located in the
cell membrane in the tested bacteria, preventing the
extrusion of antibiotics in the cytoplasm and therefore
restoring their activity as observed in this study [55, 56].
This is the first time to report the potential of the
studied extracts, particularly those from the leaves of
C. molle (CML) and the fruits of A. gabonensis (AGF) to
reverse antibiotic resistance in MDR bacteria.
Conclusion
This study provides informative data on the antimicro-
bial potential of the tested plant extracts and suggests
that extracts from Allanblackia gabonensis could be a
source of natural antibacterial products whilst Combre-
tum molle leaves extract could contain both antibacterial
substances and antibiotic-modulation agents. These
data indicate that these plants can be used to fight bac-
terial infections and especially those involving MDR
phenotypes.
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